fbpx

The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry

annabis-based medicinal products (CBMPs) have shown promising preclinical activity in inflammatory bowel disease (IBD). However, clinical trials have not demonstrated effects on inflammation. This study aims to analyze changes in health-related quality of life (HRQoL) and adverse events in IBD patients prescribed CBMPs.

The post The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry appeared first on Society of Cannabis Clinicians.

Leave a Reply

Generated by Feedzy
%d